Sligo, 9th February 2012 - Abbott plans to invest €85 million at its pharmaceutical manufacturing operation in Sligo. The investment will result in the creation of up to approximately 175 highly ...

Abbott Laboratories will make new investments in US manufacturing, with the impact of tariffs on medical devices and diagnostics looming over the industry. It expects to spend $500 million on two ...

ABBOTT PARK, Ill., June 23, 2014 /PRNewswire/ -- Abbott ABT-0.29% today announced a definitive agreement to acquire Veropharm, a leading Russian pharmaceutical manufacturer. Under the terms of the ...

CEO Robert Ford said Abbott's manufacturing base was built on the tenet of locating production as close as possible to the customer. (Abbott) Like Johnson & Johnson did during its earnings call the ...

Abbott said it will acquire Veropharm for up to $631 million including assumption of debt, in a deal the buyer said reflected its commitments to growing in Russia, and expanding its worldwide presence ...